KaNDy Therapeutics is a company that provides Vasomotor symptom, Health care, Pharmacy and Therapeutics and more. KaNDy Therapeutics is headquartered in United Kingdom Herefordshire. KaNDy Therapeutics was founded in 2017. and was founded by Mary Kerr, Mike Trower. KaNDy Therapeutics has a total of 74 patents
Related Topics
Vasomotor symptomHealth carePharmacy and TherapeuticsVasomotorAddictionHormoneHot flashOpioid use disorderNaltrexoneOpioid antagonistMethadoneBuprenorphineMenopauseClinical trial
visualizing technology portfolio of hot application areas and blank areas for KaNDy Therapeutics
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for KaNDy Therapeutics
Sign up to view the full data
Free Trial Now
Download
Top Related Companies
Sign up to view the full data
Free Trial Now
KaNDy Therapeutics Frequently Asked Questions
What is KaNDy Therapeutics's industry?
KaNDy Therapeutics is in the industry of:Research and Development in the Physical, Engineering, and Life SciencesPharmaceutical and Medicine Manufacturing
What technical fields has KaNDy Therapeutics researched?
KaNDy Therapeutics has researched the technical fields related toVasomotor symptomHealth carePharmacy and TherapeuticsVasomotorAddictionHormoneHot flashOpioid use disorderNaltrexoneOpioid antagonistMethadoneBuprenorphineMenopauseClinical trial
What is KaNDy Therapeutics's total number of patents?
KaNDy Therapeutics is a provider of bio-technical research and development services intended to offer treatment for common, chronic debilitating female...
What is KaNDy Therapeutics's official website?
KaNDy Therapeutics's official website is http://www.kandytherapeutics.com.